News
Business Development Manager Position Opening
Yuhan USA Corporation– 유한양행 미국 법인 Work locations: San Diego, CA or Boston, MA Employee type: Full-time Visa Sponsorship available: No Contact Information: info@yuhan-usa.com 유한USA는
Yuhan Corporation acquires Progen, a multi-target antibody company based in South Korea for total of $23M investment
Yuhan Corporation announced on April 5, 2023, that it has signed an investment agreement to secure the largest shareholder stake in Progen Inc., a company
Yuhan Corporation confirms efficacy of Lazertinib, a new drug for NSCLC in Phase 3 trial
The top line results for the phase 3 clinical trial of the 3rd generation EGFR TKI ‘Lazertinib’ being developed by Yuhan Corporation have been announced.
PCS12852 Improves Gastric Emptying in Gastroparesis Patients
Processa Pharmaceuticals announced that positive gastric emptying results from its PCS12852 Phase 2A Proof-of-Concept trial in patients with moderate to severe gastroparesis. PCS12852 is a
Yuhan’s ‘Lazertinib’ Phase 3 topline data shows ‘PFS Improvement’ as first line of therapy
On 14 October, Yuhan announced top-line Phase 3 study data of Lazertinib as 1st line treatment that has significantly improved progression-free survival (PFS) as the
[Job Opening] Business Development Manager – Boston office
[채용 공고]유한양행 미국 법인 – 유한 USA Position:Business Development Manager Work location:Boston, MA Responsibilities:1.개방형 기술혁신 및 In/Out Licensing Partnering 사업개발2.유망 바이오 기업 발굴 및 전략적